| Product Code: ETC10223208 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of prostate-specific antigen blood-based biomarkers in Guyana saw significant growth in 2024, with top exporting countries being the USA, Brazil, India, Netherlands, and South Korea. The Herfindahl-Hirschman Index (HHI) indicated a high concentration of imports in 2023, which slightly decreased but remained high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 37.59%, with a remarkable growth rate of 113.31% from 2023 to 2024. This data suggests a strong and rapidly expanding market for prostate-specific antigen biomarkers in Guyana.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.8 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about prostate cancer screening and early detection in Guyana |
4.2.2 Growing prevalence of prostate cancer in the region |
4.2.3 Advancements in diagnostic technologies for detecting prostate-specific antigen levels |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Guyana |
4.3.2 High cost associated with prostate-specific antigen testing |
4.3.3 Cultural barriers and stigmas related to prostate cancer screening in Guyana |
5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2021 - 2031F |
6.1.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2021 - 2031F |
6.1.5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2021 - 2031F |
6.1.6 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2021 - 2031F |
6.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2021 - 2031F |
6.2.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2021 - 2031F |
6.2.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2021 - 2031F |
6.2.5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2021 - 2031F |
6.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2021 - 2031F |
6.3.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2021 - 2031F |
6.3.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2021 - 2031F |
6.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2021 - 2031F |
6.5.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Percentage increase in the number of prostate-specific antigen tests conducted annually |
8.2 Adoption rate of newer blood-based biomarker tests for prostate cancer detection |
8.3 Rate of referral to specialists for further evaluation following abnormal prostate-specific antigen results |
9 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
9.4 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
10 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2024 |
10.2 Guyana Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here